Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.
Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
By suggesting that BA–MCYs can regulate the production of bile acids, the findings of a recent study offer insights for treating metabolic conditions such as diabetes.
Specific microbial metabolites can lead to new therapies for skin barrier disorders such as eczema and psoriasis.
Chemical biology offers useful methods to study microbial systems and gather molecular information about microbiomes.
Probiotics such as Lactobacillus can complement breast cancer therapy to improve prevention and treatment.
High levels of bile acids drive bacterial colonization of the gut and exacerbate gut inflammation by altering the intestinal environment.
The effects of coffee on health may be mediated by gut microbes such as L. asaccharolyticus and their metabolites.
Mice born to mothers exposed to Akkermansia muciniphila during pregnancy showed improvements in stem cell activity.
